Previously untreated stageIIIB/IV NSCLC
Conditions
Interventions
CPT-11+S-1
Sponsors
West Japan Oncology Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Histologically or cytologically confirmed StageIIIB/IV previously untreated NSCLC
Exclusion criteria
Exclusion criteria: Symptomatic brain metastasis SVC symdrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate | — |
Countries
Japan
Contacts
Public ContactShinichiro Nakamura
West Japan Oncology Group WJOG datacenter
Outcome results
None listed